CODEXIS INC. - COMMON

Codexis Announces New Employment Inducement Grants

15 фев 2023 16:05:00 Источник Nasdaq GlobeNewswire

Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23

09 фев 2023 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Announces Appointment of Sri Ryali as Chief Financial Officer

23 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Announces Appointment of H. Stewart Parker to Board of Directors

20 дек 2022 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Provides Update on Prioritized Corporate Strategy

29 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire

Codexis to Participate in Piper Sandler 34th Annual Healthcare Conference

16 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Healthcare Conferences

08 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire

Codexis Reports Third Quarter 2022 Financial Results

03 ноя 2022 16:05:02 Источник Nasdaq GlobeNewswire

Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel

01 ноя 2022 08:00:03 Источник Nasdaq GlobeNewswire

Codexis to Report Third Quarter 2022 Financial Results on November 3

20 окт 2022 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer

03 окт 2022 08:00:02 Источник Nasdaq GlobeNewswire

Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors

03 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire

Codexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field

14 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Reports Second Quarter 2022 Financial Results

04 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire

Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis

02 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire

Codexis Announces CEO Transition Effective August 9, 2022

18 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)

14 июл 2022 16:06:00 Источник Nasdaq GlobeNewswire

Codexis Announces Preliminary Second Quarter 2022 Results and Updates Guidance

14 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Announces the Publication of Research Demonstrating Proof of Concept for Chemoenzymatic Site-Selective Bioconjugation of Native Peptides

17 июн 2022 08:00:00 Источник Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Healthcare Conferences

25 май 2022 16:05:00 Источник Nasdaq GlobeNewswire